NCT01925755View on ClinicalTrials.gov

Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients

CompletedOBSERVATIONAL

Enrollment

209

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

July 31, 2015

Conditions

StrokeEmbolism

Interventions

OTHER

Rivaroxaban ( Xarelto, BAY59-7939)

Patients with prior stroke or TIA history and who have never taken anticoagulation treatment regarding AF before. One film-coated tablet contains Rivaroxaban 15 mg or 20mg

Trial Locations (1)

Unknown

Many Locations